Jacobs Levy Equity Management, Inc Atara Biotherapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.23 - $1.74 $49,240 - $372,516	214,090 Added 37.77%	780,986 $398,000
Q3 2023 Nov 16, 2023	BUY	$1.41 - $2.31 $775,456 - $1.27 Million	549,969 Added 3249.06%	566,896 $839,000
Q2 2023 Aug 14, 2023	SELL	$1.5 - $3.04 $956,892 - $1.94 Million	-637,928 Reduced 97.42%	16,927 $27,000
Q1 2023 May 15, 2023	SELL	$2.8 - $5.46 $863,567 - $1.68 Million	-308,417 Reduced 32.02%	654,855 $1.9 Million
Q4 2022 Feb 14, 2023	BUY	$2.85 - $5.18 $1.73 Million - $3.15 Million	607,947 Added 171.1%	963,272 $3.16 Million
Q3 2022 Nov 15, 2022	BUY	$2.85 - $8.73 $1.01 Million - $3.1 Million	355,325 New	355,325 $1.34 Million
Q3 2021 Nov 15, 2021	SELL	$11.99 - $17.9 $1.4 Million - $2.09 Million	-116,722 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$12.89 - $16.58 $618,049 - $794,977	47,948 Added 69.72%	116,722 $1.82 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $962,836 - $1.42 Million	68,774 New	68,774 $988,000
Q4 2020 Feb 16, 2021	SELL	$12.67 - $26.23 $1.49 Million - $3.08 Million	-117,539 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$11.92 - $15.87 $128,366 - $170,904	-10,769 Reduced 8.39%	117,539 $1.52 Million
Q2 2020 Aug 17, 2020	BUY	$7.53 - $14.93 $873,186 - $1.73 Million	115,961 Added 939.18%	128,308 $1.87 Million
Q1 2020 May 15, 2020	SELL	$5.69 - $17.78 $117,970 - $368,632	-20,733 Reduced 62.68%	12,347 $105,000
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $360,241 - $555,413	33,080 New	33,080 $545,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.